Lamia Ghezali

Lamia Ghezali

Auto-generated profile, based on publicly available information

Lamia Ghezali

Genetics and Pathogenesis of Cerebrovascular Diseases, Inserm, Paris Diderot University, Paris, France

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2015 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
CCCarmen Capone
Carmen Capone
ECEmmanuel COGNAT
Emmanuel COGNAT
LGLamia Ghezali
Lamia Ghezali
CBCéline Baron‐Menguy
Céline Baron‐Menguy
DADéborah Aubin
Déborah Aubin
AJAnne Joutel
Anne Joutel

1 August 2016 in eLife
Verified
Journal Article
Open access
CCCarmen Capone
Carmen Capone
FDFabrice Dabertrand
Fabrice Dabertrand
CBCeline Baron-Menguy
Celine Baron-Menguy
ACAthena Chalaris
Athena Chalaris
LGLamia Ghezali
Lamia Ghezali
AJAnne Joutel
Anne Joutel
Cerebral small vessel disease (SVD) is a leading cause of stroke and dementia. CADASIL, an inherited SVD, alters cerebral artery function, compromising blood flow to the working brain. TIMP3 (tissue inhibitor of metalloproteinase 3) accumulation in the vascular extracellular matrix in CADASIL is a key contributor to cerebrovascular dysfunction. However, the linkage between elevated TIMP3 and compromised cerebral blood flow (CBF) remains unknown. Here, we show that TIMP3 acts through inhibition of the metalloprotease ADAM17 and HB-EGF to regulate cerebral arterial tone and blood flow responses. In a clinically relevant CADASIL mouse model, we show that exogenous ADAM17 or HB-EGF restores cerebral arterial tone and blood flow responses, and identify upregulated voltage-dependent potassium channel (KV) number in cerebral arterial myocytes as a heretofore-unrecognized downstream effector of TIMP3-induced deficits. These results support the concept that the balance of TIMP3 and ADAM17 activity modulates CBF through regulation of myocyte KV channel number.

1 January 2017 in Hypertension
Verified
Journal Article
Closed access
PDF file
CBCeline Baron-Menguy
Celine Baron-Menguy
VDValérie Domenga-Denier
Valérie Domenga-Denier
LGLamia Ghezali
Lamia Ghezali
FFFrank M. Faraci
Frank M. Faraci
AJAnne Joutel
Anne Joutel
CADASIL (Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy), the most frequent genetic cause of stroke and vascular dementia, is caused by highly stereotyped mutations in the NOTCH3 receptor, which is predominantly expressed in vascular smooth muscle. The well-established TgNotch3 R169C mouse model develops characteristic features of the human disease, with deposition of NOTCH3 and other proteins, including TIMP3 (tissue inhibitor of metalloproteinase 3), on brain vessels, as well as reduced maximal dilation, and attenuated myogenic tone of cerebral arteries, but without elevated blood pressure. Increased TIMP3 levels were recently shown to be a major determinant of altered myogenic tone. In this study, we investigated the contribution of TIMP3 and Notch3 signaling to the impairment of maximal vasodilator capacity caused by the archetypal R169C mutation. Maximally dilated cerebral arteries in TgNotch3 R169C mice exhibited a decrease in lumen diameter over a range of physiological pressures that occurred before myogenic tone deficits. This defect was not prevented by genetic reduction of TIMP3 in TgNotch3 R169C mice and was not observed in mice overexpressing TIMP3. Knock-in mice with the R169C mutation ( Notch3 R170C/R170C ) exhibited similar reductions in arterial lumen, and both TgNotch3 R169C and Notch3 R170C/R170C mice showed increased cerebral artery expression of Notch3 target genes. Reduced maximal vasodilation was prevented by conditional reduction of Notch activity in smooth muscle of TgNotch3 R169C mice and mimicked by conditional activation of Notch3 in smooth muscle, an effect that was blood pressure–independent. We conclude that increased Notch3 activity mediates reduction in maximal dilator capacity of cerebral arteries in CADASIL and may contribute to reductions in cerebral blood flow.

25 August 2018 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
LGLamia Ghezali
Lamia Ghezali
CCCarmen Capone
Carmen Capone
CBCéline Baron‐Menguy
Céline Baron‐Menguy
JRJulien Ratelade
Julien Ratelade
SCSøren Christensen
Søren Christensen
AJAnne Joutel
Anne Joutel

1 April 2013 in Experimental Cell Research
Verified
Journal Article
Closed access
LGLamia Ghezali
Lamia Ghezali
DLDavid Yannick Leger
David Yannick Leger
Youness LimamiYouness Limami
Youness Limami
JCJeanne Cook-Moreau
Jeanne Cook-Moreau
JBJean-Louis Beneytout
Jean-Louis Beneytout
BLBertrand Liagre
Bertrand Liagre

16 April 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LGLamia Ghezali
Lamia Ghezali
BLBertrand Liagre
Bertrand Liagre
Youness LimamiYouness Limami
Youness Limami
JBJean-Louis Beneytout
Jean-Louis Beneytout
DLDavid Yannick Leger
David Yannick Leger
Differentiation therapy is a means to treat cancer and is induced by different agents with low toxicity and more specificity than traditional ones. Diosgenin, a plant steroid, is able to induce megakaryocytic differentiation or apoptosis in human HEL erythroleukemia cells in a dose-dependent manner. However, the exact mechanism by which diosgenin induces megakaryocytic differentiation has not been elucidated. In this study, we studied the involvement of Sonic Hedgehog in megakaryocytic differentiation induced by diosgenin in HEL cells. First, we showed that different elements of the Hedgehog pathway are expressed in our model by qRT-PCR. Then, we focused our interest on key elements in the Sonic Hedgehog pathway: Smoothened receptor, GLI transcription factor and the ligand Sonic Hedgehog. We showed that Smoothened and Sonic Hedgehog were overexpressed in disogenin-treated cells and that GLI transcription factors were activated. Then, we showed that SMO inhibition using siSMO or the GLI antagonist GANT-61, blocked megakaryocytic differentiation induced by diosgenin in HEL cells. Furthermore, we demonstrated that Sonic Hedgehog pathway inhibition led to inhibition of ERK1/2 activation, a major physiological pathway involved in megakaryocytic differentiation. In conclusion, our study reports, for the first time, a crucial role for the Sonic Hedgehog pathway in diosgenin-induced megakaryocytic differentiation in HEL cells.